BTX's New In Vivo Electroporation System

Published: May 29, 2012

May 29, 2012 -- The New AgilePulse® In Vivo Electroporation System possesses unique, variable pulse amplitude technology for vaccine delivery or gene therapy applications.

Patented Pulse Agile™ waveforms consists of multiple, low to high voltage pulses with variable pulse lengths, which promotes greater cell membrane poration; resulting in maximum transfection efficiency with minimal damage to the cells or tissues. Gene expression in skin is 100-fold higher1 when delivery is enhanced by electroporation compared to injection alone.


• Patented Pulse Agile® technology

• Resistance measurement for proper needle placement and reproducibility

• Specially designed needle arrays for intra-muscular or intra-dermal applications


• Enhanced immune response1

• Increased Ag-specific T-cell response1

• Gene expression is 100-fold higher1

Visit the BTX website at for more information on products, protocols or to view video tutorials for a variety of applications.

To learn more about this exciting new technology or other BTX electroporation or electrofusion products, contact:


84 October Hill Road

Holliston, Massachusetts 01746 USA

Toll Free: 800-272-2775

Phone: 508-893-8999 ext 167

Fax: 508-429-5732



Back to news